D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
EPIX holding history
ESSA Pharma Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EPIX overviewAll 13F holders of EPIXFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −62,955−100.0% | Sold out | Holders |
| Q3 2024 | 62,955 | $381.5K | <0.1% | −526−0.8% | Reduced | Holders |
| Q2 2024 | 63,481 | $333.9K | <0.1% | −1,600−2.5% | Reduced | Holders |
| Q1 2024 | 65,081 | $552.5K | <0.1% | −134,572−67.4% | Reduced | Holders |
| Q4 2023 | 199,653 | $1.32M | <0.1% | +31,603+18.8% | Added | Holders |
| Q3 2023 | 168,050 | $519.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 168,050 | $453.7K | <0.1% | −4,171−2.4% | Reduced | Holders |
| Q1 2023 | 172,221 | $511.5K | <0.1% | −78,164−31.2% | Reduced | Holders |
| Q4 2022 | 250,385 | $631.0K | <0.1% | −249,448−49.9% | Reduced | Holders |
| Q3 2022 | 499,833 | $910.0K | <0.1% | +159,207+46.7% | Added | Holders |
| Q2 2022 | 340,626 | $1.07M | <0.1% | +39,834+13.2% | Added | Holders |
| Q1 2022 | 300,792 | $1.86M | <0.1% | +166,278+123.6% | Added | Holders |
| Q4 2021 | 134,514 | $1.91M | <0.1% | −181,217−57.4% | Reduced | Holders |
| Q3 2021 | 315,731 | $2.53M | <0.1% | +315,731 | New | Holders |